Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Hepatic Artery Transfusion of NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer: a Prospective, Multicenter Clinical Trial

NCT05248048 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT05248048
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05248048 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Hepatic Artery Transfusion of NKG2D CAR-T Cells to Treat Patients With Previously Treated Liver Metastatic Colorectal Cancer: a Prospective, Multicenter Clinical Trial
Lead sponsor
The Third Affiliated Hospital of Guangzhou Medical University
Phase
Phase 1
Overall status
Unknown status
Start date
September 13, 2021
Completion date
October 31, 2022
Enrollment
9 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

refractory metastatic colorectal cancer